Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-29

Clinical Trial Update: Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the effects of lumiracoxib and ibuprofen on blood pressure and urinary eicosanoid excretion in patients with osteoarthritis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)
  • Lumiracoxib (Lumiracoxib)

Snippet

Sponsor: Novartis | Conditions: Osteoarthritis With Controlled Hypertension | Phase 4 | Status: COMPLETED